among patients at high risk of infection ( with or without liver disease ) anti-hcv antibodies were found in 85 % of prospectively followed patients with post-transfusion non-a , non-b hepatitis , 62 % of patients with chronic hepatitis or cirrhosis and a history of blood transfusion , 70 % of haemophiliacs receiving replacement therapy , 70 % of intravenous drug abusers , and 20 % of haemodialysis patients .
C0023895
liver disease
C0023890
cirrhosis